ReviewFrontiers in oncology2022

TP53 Co-Mutations in Advanced EGFR-Mutated Non-Small Cell Lung Cancer: Prognosis and Therapeutic Strategy for Cancer Therapy.

Surui Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.